Mixed neuropathology in frontotemporal lobar degeneration

References

• Seo SW, Thibodeau MP, Perry DC, Hua A, Sidhu M, Sible I, et al. Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration. Neurology. 2018;90:e1047–56.
   PubMed Web of Science ®Google Scholar
• Coulthard E, Love S. A broader view of dementia: multiple co-pathologies are the norm. Brain. 2018;141:1894–7.
   PubMed Web of Science ®Google Scholar
• Boyle P, Yu L, Wilson R, Schneider J, Bennett D. Relation of neuropathology with cognitive decline among older persons without dementia. Front Aging Neurosci. 2013;5:50.
   PubMed Web of Science ®Google Scholar
• Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197–204.
   PubMed Web of Science ®Google Scholar
• Kawas CH, Kim RC, Sonnen JA, Bullain SS, Trieu T, Corrada MM. pathologies are common and related to dementia in the oldest-old: the 90+ Study. Neurology. 2015;85:535–42.
   PubMed Web of Science ®Google Scholar
• Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004;62:1148–55.
   PubMed Web of Science ®Google Scholar
• Nag S, Yu L, Capuano AW, Wilson RS, Leurgans SE, Bennett DA, et al. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol. 2015;77:942–52.
   PubMed Web of Science ®Google Scholar
• Mann DM, Snowden JS. Frontotemporal lobar degeneration: pathogenesis, pathology and pathways to phenotype. Brain Pathol. 2017;44:1–23.
   Google Scholar
• Kovacs GG. Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine. Int J Mol Sci. 2016;17:189.
   PubMed Web of Science ®Google Scholar
• Saxon JA, Harris JM, Thompson JC, Jones M, Richardson AMT, Langheinrich T, et al. Semantic dementia, progressive non-fluent aphasia and their association with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88:711–2.
   PubMed Web of Science ®Google Scholar
• McAleese KE, Walker L, Erskine D, Thomas AJ, Mckeith IG, Attems J. TDP-43 pathology in Alzheimer’s disease, dementia with Lewy bodies, and ageing. Brain Pathol. 2017;27:472–9.
   PubMed Web of Science ®Google Scholar
• James BD, Wilson RS, Boyle PA, Trojanowski JQ, Bennett DA, Schneider JA. TDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia. Brain 2016;139:2983–93.
   PubMed Web of Science ®Google Scholar
• Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National institute on aging-Alzheimer’s association guidelines for the neuropathologic assessment of Alzheimer’s disease: A practical approach. Acta Neuropathol. 2012;123:1–11.
   PubMed Web of Science ®Google Scholar
• Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112:389–404.
   PubMed Web of Science ®Google Scholar
• Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, et al. Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol. 2008;18:484–96.
   PubMed Web of Science ®Google Scholar
• Thal DR, Rüb U, Orantes M, Braak H. Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 2002;58:1791–800.
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K, Rüb U, De Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211.
   PubMed Web of Science ®Google Scholar
• MacKenzie IRA, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119:1–4.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122:111–3.
   PubMed Web of Science ®Google Scholar
• Skrobot OA, Attems J, Esiri M, Hortobágyi T, Ironside J, Kalaria RN, et al. Vascular Cognitive Impairment Neuropathology Guidelines (VCING): a UK multi-centre consensus study. Neuropathol Appl Neurobiol. 2016;139:2957–69.
   Google Scholar
• Love S, Perry A, Ironside J, Budka H. Greenfield’s neuropathology. 9th ed. Boca Raton, FL: CRC Press; 2015.
   Google Scholar
• Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 2017;134:171–86.
   PubMed Web of Science ®Google Scholar
• Thal DR, von Arnim CA, Griffin WS, Mrak RE, Walker L, Attems J, et al. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies. J Neural Transm. 2015;122:1007–18.
   PubMed Web of Science ®Google Scholar
• Spires-Jones TL, Attems J, Thal DR. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol. 2017;134:187–205.
   PubMed Web of Science ®Google Scholar
• Lee SE, Rabinovici GD, Mayo MC, Wilson SM, Seeley WW, Dearmond SJ, et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol. 2011;70:327–40.
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Rozemuller AJM, van Swieten JC, Gelpi E, Majtenyi K, Al-Sarraj S, et al. Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium. Neuropathol Appl Neurobiol. 2013;39:166–78.
   PubMed Web of Science ®Google Scholar
• Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Study design comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population. Am J Epidemiol. 2017;186:1026–34.
   PubMed Web of Science ®Google Scholar
• Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, et al. Concomitant Pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat Disord. 2014;20:525–9.
   PubMed Web of Science ®Google Scholar
• Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain. 2018;141:2181–93.
   PubMed Web of Science ®Google Scholar
• Josephs KA, Murray ME, Whitwell JL, Parisi JE, Petrucelli L, Jack CR, et al. Staging TDP-43 pathology in Alzheimer ‘s disease. Acta Neuropathol. 2014;127:441–50.
   PubMed Web of Science ®Google Scholar